AI-Generated Drug for Pulmonary Fibrosis Enters Clinical Trials - AI Dynamics

Skip to content

AI Dynamics

Global AI News Aggregator

Rechercher

AI-Generated Drug for Pulmonary Fibrosis Enters Clinical Trials

By

–

30 June 2023 21h25

AI generated drug in clinical trials for treatment of idiopathic pulmonary fibrosis, a chronic lung disease.

→ View original post on X — @deeplearn007

30 June 2023

AI GENERATIVE AI HEALTHCARE AI INNOVATION RESEARCH

←The Future of Work in an AI-Driven Economy

Synthetic Data: The Next Frontier for Large Language Models→

MORE ARTICLES

Paper praised for executing Gato idea with humanoid; more work desired

28 June 2026
Skild Brain AI enables robots to handle unfamiliar environments

28 June 2026
Proposal to replace Google Search with Gemini

28 June 2026
Using video to learn control representations, touch important

28 June 2026

INNOVATION GENERATIVE AI RESEARCH LLMS TOOLS MACHINE LEARNING CODE MARKET TRENDS TECHNOLOGY BUSINESS BIG TECH ETHICS ENTERPRISE AI SOFTWARE AGENTS AUTOMATION APPS COMPUTING DATA POLICY OPEN SOURCE MULTIMODAL AI REGULATION CULTURE CREATIVE AI PROMPT ENGINEERING SOCIETY ECONOMY SAFETY EDUCATION INVESTMENT AI HARDWARE AGI HARDWARE JOBS STARTUPS INDUSTRY ROBOTICS WORKFORCE SECURITY CYBERSECURITY HEALTHCARE AI SYSTEMS SUSTAINABILITY WEB3 DECENTRALIZED AI

AI Dynamics

Global AI News Aggregator

About
Archives
Contact

Rechercher